About MeI am a board certified hematologist and my area of focus is caring for patients with chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). Our multidisciplinary hematology group has extensive experience treating patients with novel therapeutics as part of clinical trials. Our goal is to eradicate the need for chemotherapy in the treatment of leukemia.
I hold the D. Warren Brown Chair of Leukemia Research, and serve as a professor of medicine, and medicinal chemistry and pharmacy for The Ohio State University. I‘m proud to have served in the military and did much of my training at Walter Reed Army Medical Center. I was rated in the top 10 percent of physicians in the nation for patient satisfaction in 2014, 2016 and 2017.
Additionally, I’m a member of the National Cancer Institute’s Leukemia Steering Committee, Chair of the Leukemia and Correlative Science Committee within the Alliance for Clinical Trials in Oncology and member of the American Society of Clinical Investigation. I have published more than 400 papers related to clinical and laboratory investigation in AML and CLL.
The best cancer treatments have never been good enough for me. As long as people are still facing cancer, I’ll keep fighting. When researchers can focus on one type of cancer every day, like we do here at The James, we can discover amazing things. I’m just one of the many physicians looking for solutions to a multitude of cancers. And I won’t stop until we’re all living in a cancer-free world.
- Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2016, 2017
- Named to the Castle Connolly list of America’s “Top Doctors” for 2017
- Best Doctor in America 2017
Specialties and conditions I treat
- Chronic Lymphocytic Leukemias
- Waldenstrom Macroglobulinemia
- Acute Myeloid Leukemias
- Myelodysplastic Syndromes
- Blood Cancers
Locations where I practice
Education and training
University of Arkansas College of Medicine
Walter Reed Army Medical Center
7/1/1992 - 6/30/1994
More about my work
Johns Hopkins Medical Center
7/1/1996 - 6/30/1997
Walter Reed Army Medical Center
7/1/1994 - 6/30/1996
American Board of Internal Medicine
American Board of Internal Medicine (Subspecialty: Hematology)
American Board of Internal Medicine (Subspecialty: Medicine Oncology)
News about me
- December 2016 MedTips
- Two Genetic Mutations Discovered in Subset of Acute Myeloid Leukemia
- John Byrd, MD, Named to American Society of Hematology Executive Committee
- National Collaborative Precision Medicine Trial to Treat Acute Myeloid Leukemia Launched
- 10 Ohio State Cancer Research Projects Underway With Pelotonia Funding
- Ohio State Receives Top Rating From National Cancer Institute — ‘Exceptional’ — Re-Designated As Comprehensive Cancer Center
- NOVEMBER 2014 MEDTIPS AWARDS AND ANNOUNCEMENTS
- Older And Younger Chronic Leukemia Patients May Need Different Therapy
- Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients
- Marker Distinguishes More-Aggressive From Less-Aggressive Forms Of Chronic Leukemia
- Researchers Identify a "Life-And-Death" Molecule on Chronic Leukemia Cells
- Novel Experimental Agent Is Highly Active In Cll Patients, Interim Study Shows
- Second Ohio State Cancer Drug Begins Clinical Trials Testing
- James Nurse Practioner Named Woman Of The Year
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/28/2017, Dr. Byrd has reported financial relationships with the medical device, research and/or drug companies listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.
- Leukemia and Lymphoma Society